Planning application details ref: 18817 Louth County Council

100%100% Complete (warning)

Planning Application: 18817 (Louth County Council )
File Number: 18817
Application Type: PERMISSION Planning Status: APPLICATION FINALISED
Received Date: 10/10/2018 Decision Due Date: 04/12/2018
Validated Date: 10/10/2018 Invalidated Date:
Further Info Requested: Further Info Received:
Withdrawn Date: Extend Date:
Decision Type: Conditional Decision Date: 27/11/2018
Leave to Appeal: Appeal Date:
Commenced Date: Submissions By: 13/11/2018

Applicant Details

Applicant name: Wuxi Biologics Ltd
Applicant Address:
Phone Number: Fax Number:
Corresp. Address:

Applicant Details


Proposed Development

Development Description: The application seeks amendments to the permitted development (LCC Reg. Ref. 08/822), which has been extended in duration under Reg. Ref.18/187) and relate to the medium to large scale biopharmaceutical manufacturing facility, referred to as site 2 in the planning permission. The area of the overall site subject to amendments in this application is c.20.74 hectares. The overall GFA of builings on site 2 is proposed to reduce from 57,700m2 to 54,232m2. See Site Notice for Comprehensive Description of Amendments.
Development Address: Mullagharlin and Haynestown townlands, Dundalk, Co Louth
Architect Name: Location Key: MULLAGHARLIN ROAD DUNDALK
Electoral Division: Planner: Sinead Mullen
Social Housing Exempt: Plan Enforcement #:
IPC Licence Required: No Waste Licence Required: No
Protected Structure: No Protected Structure #:
Development Name:

Proposed Development


Comments

Significant Case Flag: Comments:

Decision

Decision Date: 27/11/2018 Manager Order: 866b/18
Decision Type: Conditional Number of Conditions: 16
Grant Date: 07/01/2019 Grant Managers Order #: 866b/18
Section 47 Apply?: Part 5 Apply?:
Expiry Date: 06/01/2024
Decision Description: The application seeks amendments to the permitted development (LCC Reg. Ref. 08/822), which has been extended in duration under Reg. Ref.18/187) and relate to the medium to large scale biopharmaceutical manufacturing facility, referred to as site 2 in the planning permission. The area of the overall site subject to amendments in this application is c.20.74 hectares. The overall GFA of builings on site 2 is proposed to reduce from 57,700m2 to 54,232m2. See Site Notice for Comprehensive Description of Amendments.

Appeal Details


Appeal Details
Notification Date: BP Reference #:
Appeal Type: File Forward Date:
Submission Due Date: Submission Sent Date:
Appeal Decision: Decision Date:
Withdrawn Date: Dismissed Date:
Reason: